InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by LAPORTE KATHLEEN. Director active across 3 companies, notably 89bio, Inc.. Aggregated, 7 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €209k. History available since 17 July 2023. The latest transaction was disclosed on 15 April 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
7 of 7 declarations